Time to Clinical Response to Secukinumab Across Disease Domains Among Patients with Psoriatic Arthritis: A Pooled Post Hoc Analysis of 4 Phase 3 Trials

被引：0

作者：

Coates, Laura ^{[1
]}

McInnes, Iain ^{[2
]}

Husni, M. Elaine ^{[3
]}

Vizcaya, Cynthia ^{[4
]}

Bao, Weibin ^{[5
]}

Mease, Philip ^{[6
,7
]}

机构：

[1] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England

[2] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland

[3] Cleveland Clin, Cleveland, OH USA

[4] Novartis Pharma AG, Basel, Switzerland

[5] Novartis Pharmaceut, E Hanover, NJ USA

[6] Providence St Joseph Hlth, Swedish Med Ctr, Seattle, WA USA

[7] Univ Washington, Sch Med, Seattle, WA USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0589

引用

页码：1200 / 1203

页数：4

共 1 条

[1] International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials [J].

Orbai, Ana-Maria ;

de Wit, Maarten ;

Mease, Philip ;

Shea, Judy A. ;

Gossec, Laure ;

Leung, Ying Ying ;

Tillett, William ;

Elmamoun, Musaab ;

Duffin, Kristina Callis ;

Campbell, Willemina ;

Christensen, Robin ;

Coates, Laura ;

Dures, Emma ;

Eder, Lihi ;

FitzGerald, Oliver ;

Gladman, Dafna ;

Goel, Niti ;

Grieb, Suzanne Dolwick ;

Hewlett, Sarah ;

Hoejgaard, Pil ;

Kalyoncu, Umut ;

Lindsay, Chris ;

McHugh, Neil ;

Shea, Bev ;

Steinkoenig, Ingrid ;

Strand, Vibeke ;

Ogdie, Alexis .

ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (04) :673-680

← 1 →